4 issue of the New England Journal of Medicine . Initial findings, including that the trial had met its primary endpoint of progression free survival , were reported during the plenary session at the 55th American Society of Hematology annual meeting in December 2013.
http://ift.tt/1rwiHK5
http://ift.tt/1rwiHK5
No comments:
Post a Comment